Evidence map›Paper›PMID 39988120›Full record

ArticleBrain stimulation

Towards accredited clinical training in brain stimulation: Proceedings from the brain stimulation subspecialty summits.

Shan H Siddiqi, Leo Chen, Nicholas T Trapp, Noreen Bukhari-Parlakturk, Joseph J Taylor, Aaron D Boes, Joshua C Brown, Tracy Barbour, Joan A Camprodon, Michael D Fox and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain stimulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Shan H SiddiqiCenter for Brain Circuit Therapeutics, Mass General Brigham, Boston, MA, USA; Department of Psychiatry, Mass General Brigham, Boston, MA, USA; Division of Neurotherapeutics, McLean Hospital, Belmont, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: shsiddiqi@bwh.harvard.edu.
Leo ChenDepartment of Psychiatry, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Alfred Mental and Addiction Health, Alfred Health, Melbourne, VIC, Australia.
Nicholas T TrappDepartment of Psychiatry, University of Iowa, Iowa City, IA, USA; Iowa Neuroscience Institute, Iowa City, IA, USA.
Noreen Bukhari-ParlakturkDepartment of Neurology, Duke University School of Medicine, Durham, NC, USA; Duke Institute for Brain Sciences, Durham, NC, USA.
Joseph J TaylorCenter for Brain Circuit Therapeutics, Mass General Brigham, Boston, MA, USA; Department of Psychiatry, Mass General Brigham, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Aaron D BoesIowa Neuroscience Institute, Iowa City, IA, USA; Departments of Pediatrics and Neurology, University of Iowa, Iowa City, IA, USA.
Joshua C BrownDivision of Neurotherapeutics, McLean Hospital, Belmont, MA, USA; Harvard Medical School, Boston, MA, USA; Brain Stimulation Mechanisms Laboratory, Division of Depression and Anxiety Disorders, McLean Hospital, Belmont, MA, USA.
Tracy BarbourHarvard Medical School, Boston, MA, USA; Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA, USA.
Joan A CamprodonHarvard Medical School, Boston, MA, USA; Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA, USA.
Michael D FoxCenter for Brain Circuit Therapeutics, Mass General Brigham, Boston, MA, USA; Department of Psychiatry, Mass General Brigham, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Neurology, Brigham & Women's Hospital, Boston, MA, USA.
Brian H KopellCenter for Neuromodulation and the Bonnie and Tom Strauss Movement Disorders Center, Department of Neurosurgery, Mount Sinai Health System, New York, NY, USA.
Carlene MacMillanFermata, Brooklyn, NY, USA; Osmind, San Francisco, CA, USA; American Psychiatric Association, Washington, DC, USA.
Alfonso FasanoEdmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada; Division of Neurology, University of Toronto, Toronto, ON, Canada; Krembil Brain Institute, Toronto, ON, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA), Canada.
Robert S FisherDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Ziad NahasDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, USA.
Gonzalo J RevueltaDepartment of Neurology, Medical University of South Carlina, Charleston, SC, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Patricio Riva-PosseDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
John D RolstonCenter for Brain Circuit Therapeutics, Mass General Brigham, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Mapping & Engineering Neural Dynamics (MEND) Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Katherine ScangosDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA.
Mouhsin M ShafiHarvard Medical School, Boston, MA, USA; Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Andrew H SmithCenter for Neuromodulation and the Bonnie and Tom Strauss Movement Disorders Center, Department of Neurosurgery, Mount Sinai Health System, New York, NY, USA.
Joshua WongDepartment of Neurology, University of Florida, Gainesville, FL, USA.
Casey H HalpernOsmind, San Francisco, CA, USA.
Helen S MaybergDepartment of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nolan R WilliamsDepartment of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford University, California, USA.

Funding

BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC)UM1NS132358 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Suzanne N Haber, Elizabeth M. C. Hillman · 2023 to 2026
$17.5M
Institutional Career Development CoreKL2TR002554 · NCATS · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2018 to 2022
$8.2M
Clinical Translation of Ultrasonic Ketamine Uncaging for Non-Opioid Therapy of Chronic PainUG3NS115637 · NINDS · STANFORD UNIVERSITY · PI Raag D Airan, Boris Dov Heifets · 2019 to 2026
$8.0M
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
Efficacy of biomarker-guided rTMS for treatment resistant depressionR01MH118388 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI BHATI, MAHENDRA T, GUNNING, FAITH M · 2019 to 2025
$6.2M
Toward Connectomic Deep Brain Stimulation in Obsessive Compulsive DisorderR01MH130666 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2022 to 2026
$3.9M
A Transdiagnostic Assessment of Electroconvulsive Therapy Modulation of Anhedonia and Reward circuitry: Targets, Biomarkers and Predictors of ResponseR01MH112737 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CAMPRODON, JOAN A · 2017 to 2021
$3.8M
A translational approach for novel mechanisms of epigenetic regulation in treatment responses: toward a precision medicine modelR01MH128311 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Carla Nasca · 2022 to 2026
$3.6M
Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy CircuitR01NS127892 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2022 to 2026
$3.4M
Utilizing changes in human brain connectivity to establish a dose-response relationship involved in the therapeutic actions of prefrontal brain stimulation on depression symptomsR01MH122754 · NIMH · STANFORD UNIVERSITY · PI WILLIAMS, NOLAN R. · 2020 to 2024
$2.7M
A causal wiring diagram of transdiagnostic brain functionsR01MH136248 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI Shan Siddiqi · 2024 to 2026
$2.3M
Suicide Circuit Therapeutics: Engaging Novel Targets with Rapid and Individualized MRI-Guided Accelerated TMSR61MH132869 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CAMPRODON, JOAN A · 2023 to 2024
$2.1M
NCATS NIH HHS KL2 TR002554NIA NIH HHS R21 AG078692NIA NIH HHS R21 AG081925NIMH NIH HHS K23 MH125145NIMH NIH HHS R01 MH112737NIMH NIH HHS R01 MH113929NIMH NIH HHS R01 MH118388NIMH NIH HHS R01 MH122754NIMH NIH HHS R01 MH125160NIMH NIH HHS R01 MH128311NIMH NIH HHS R01 MH130666NIMH NIH HHS R01 MH136248NIMH NIH HHS R21 MH126271NIMH NIH HHS R21 MH131878NIMH NIH HHS R61 MH132869NINDS NIH HHS R01 NS127892NINDS NIH HHS R21 NS123813NINDS NIH HHS UG3 NS115637NINDS NIH HHS UM1 NS132358Wellcome Trust
6 · The paper itself

Abstract

The rapid development and clinical use of brain stimulation has renewed debates about whether to define and accredit a pathway for clinical subspecialty training. To address this, the Brain Stimulation Subspecialty Summits (BraSSS) were convened in 2023 and 2024, featuring international leaders in brain stimulation across psychiatry, neurology, neurosurgery, psychology, and neuroscience. Both meetings included two days of lectures and debates focused on clinical content, emerging science, and educational standards. The 2023 meeting was held at Brigham & Women's Hospital and Harvard University, where 54 attendees reached a consensus that the subspecialty is adequately developed to warrant formal recognition and initiated debates regarding the name and scope of the subspecialty. The 2024 meeting was held at Stanford University, where 56 attendees developed a content outline, organized committees, and reached a consensus to form an independent society focused on developing and maintaining unbiased accreditation standards. "Brain stimulation" was chosen democratically as the name of the subspecialty. Clinicians from multiple primary specialties may enter this subspecialty training track. While individual programs may have a specific area of focus (e.g. interventional psychiatry or epilepsy), our expectation is that accredited brain stimulation programs will provide training experiences that cross specialties and stimulation modalities. Several potential unintended consequences were discussed, and plans were developed to address them. Overall, subspecialty recognition was deemed to be beneficial to the brain stimulation field, with a goal to launch an associated society and start the process of accrediting existing US and Canadian programs in 2025.

Indexed as

AccreditationBrainHumansNeurology

Identifiers

PMID39988120
PMCPMC13222746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.